Masatoshi Asano

683 total citations
8 papers, 515 citations indexed

About

Masatoshi Asano is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Masatoshi Asano has authored 8 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Masatoshi Asano's work include Cervical and Thoracic Myelopathy (3 papers), Spine and Intervertebral Disc Pathology (2 papers) and Spinal Fractures and Fixation Techniques (1 paper). Masatoshi Asano is often cited by papers focused on Cervical and Thoracic Myelopathy (3 papers), Spine and Intervertebral Disc Pathology (2 papers) and Spinal Fractures and Fixation Techniques (1 paper). Masatoshi Asano collaborates with scholars based in Japan and United States. Masatoshi Asano's co-authors include Kazuo Yonenobu, Noboru Hosono, Keiro Ono, Motoki Iwasaki, Keiju Fujiwara, Kazuo Hiroshima, Shota Takenaka, Toshitada Miwa, Tomoya Yamashita and Shinya Okuda and has published in prestigious journals such as Journal of Clinical Oncology, Spine and Archives of Orthopaedic and Trauma Surgery.

In The Last Decade

Masatoshi Asano

8 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masatoshi Asano Japan	6	479	448	23	21	14	8	515
Enrique Izquierdo Spain	11	553 1.2×	339 0.8×	15 0.7×	17 0.8×	10 0.7×	28	572
Wenyuan Sui China	12	264 0.6×	137 0.3×	13 0.6×	7 0.3×	3 0.2×	33	295
Sung-Soo Chung South Korea	17	733 1.5×	613 1.4×	9 0.4×	32 1.5×	6 0.4×	26	795
Henry Soeharno Singapore	6	327 0.7×	296 0.7×	5 0.2×	45 2.1×	17 1.2×	12	391
Yasumitsu Ajiro Japan	9	334 0.7×	292 0.7×	5 0.2×	42 2.0×	3 0.2×	12	380
Tim Yoon United States	7	283 0.6×	283 0.6×	9 0.4×	3 0.1×	25 1.8×	12	353
G. Pech-Gourg France	11	244 0.5×	212 0.5×	7 0.3×	4 0.2×	2 0.1×	35	349
Eugene Tze-Chun Lau Singapore	9	232 0.5×	167 0.4×	4 0.2×	17 0.8×	5 0.4×	21	303
Carolyn Hardin United States	6	232 0.5×	161 0.4×	38 1.7×	4 0.2×	2 0.1×	8	294
Felisa Sánchez-Mariscal Spain	10	371 0.8×	263 0.6×	5 0.2×	4 0.2×	8 0.6×	28	385

Countries citing papers authored by Masatoshi Asano

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Asano more than expected).

Fields of papers citing papers by Masatoshi Asano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Asano. The network helps show where Masatoshi Asano may publish in the future.

Co-authorship network of co-authors of Masatoshi Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Asano. A scholar is included among the top collaborators of Masatoshi Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Asano. Masatoshi Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Harano, Kenichi, Shin Nishio, Kazuhiro Takehara, et al.. (2024). Neoadjuvant combination treatment of olaparib and pembrolizumab for patients with HRD-positive advanced ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5545–5545. 6 indexed citations

2.

Taniguchi, Hiroya, Taroh Satoh, Shigenori Kadowaki, et al.. (2023). Tissue-agnostic efficacy of trastuzumab deruxtecan (T-DXd) in advanced solid tumors with HER2 amplification identified by plasma cell-free DNA (cfDNA) testing: Results from a phase 2 basket trial (HERALD/EPOC1806).. Journal of Clinical Oncology. 41(16_suppl). 3014–3014. 19 indexed citations

3.

Takenaka, Shota, Takashi Kaito, Noboru Hosono, et al.. (2014). Neurological manifestations of thoracic myelopathy. Archives of Orthopaedic and Trauma Surgery. 134(7). 903–912. 24 indexed citations

4.

Takagi, Mari, Yoshiro Tanio, Shinya Miura, et al.. (2008). [Multidisciplinary strategy for lung cancer patients with bone metastasis].. PubMed. 35(10). 1783–6. 1 indexed citations

5.

Ito, Tetsuhide, et al.. (1998). [Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].. PubMed. 25(10). 1575–80. 1 indexed citations

6.

Asano, Masatoshi, Keiju Fujiwara, Kazuo Yonenobu, & Kazuo Hiroshima. (1996). Post-traumatic Syringomyelia. Spine. 21(12). 1446–1453. 28 indexed citations

7.

Yonenobu, Kazuo, et al.. (1992). Laminoplasty Versus Subtotal Corpectomy| A Comparative Study of Results in Multisegmental Cervical Spondylotic Myelopathy. Spine. 17(11). 1281–1284. 214 indexed citations

8.

Yonenobu, Kazuo, Noboru Hosono, Motoki Iwasaki, Masatoshi Asano, & Keiro Ono. (1991). Neurologic Complications of Surgery for Cervical Compression Myelopathy. Spine. 16(11). 1277–1282. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact